Skip to main content
SpringerLink
Log in

Multidisciplinary Approach to Lung Cancer Care

  • Chapter
  • First Online:
Lung Cancer

Part of the book series: Respiratory Medicine ((RM))

Abstract

Multidisciplinary lung cancer care is here to stay. It is mandated for accreditation of lung cancer programs in many states. A comprehensive review of the literature reveals a swell of enthusiasm for multidisciplinary care although the data in favor is not beyond reproach. Good-quality data is lacking for the most. Being mandated, a randomized clinical trial to resolve the controversy is not likely to take place on ethical grounds. The critics argue that cost and efficiency of care, mainly on the provider side, as well as significant improvement in outcomes despite low implementation over the last two decades are perennial impediments to wider acceptance. “Multidisciplinary care” is poorly defined and encompasses a wide spectrum of activities. This chapter summarizes these activities within their structural boundaries, economical and other. It lays out a framework for groups entertaining to form, revise, or just simply check how their multidisciplinary lung cancer care should look.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Borras JM, Albreht T, Audisio R, Briers E, Casali P, Esperou H, et al. Policy statement on multidisciplinary cancer care. Eur J Cancer. 2014;50(3):475–80.

    Article  PubMed  Google Scholar 

  2. Selby P, Gillis C, Haward R. Benefits from specialised cancer care. Lancet. 1996;348(9023):313–8.

    Article  CAS  PubMed  Google Scholar 

  3. Lawler M, Banks I, Law K, Albreht T, Armand J-P, Barbacid M, et al. The European cancer patient’s bill of rights, update and implementation 2016. ESMO Open. 2016;1(6):e000127.

    Article  PubMed  Google Scholar 

  4. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.

    Article  PubMed  Google Scholar 

  5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

    Article  PubMed  Google Scholar 

  6. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e278S–313S.

    Article  CAS  PubMed  Google Scholar 

  7. Duma N, Santana-Davila R, Molina JR, editors. Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clinic proceedings. Amsterdam: Elsevier; 2019.

    Google Scholar 

  8. Kris MG, Johnson BE, Berry LD, Kwiatkowski DJ, Iafrate AJ, Wistuba II, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998–2006.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Blum TG, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, et al. The European initiative for quality management in lung cancer care. Eur Respir Soc. 2014;43:1254.

    Article  Google Scholar 

  10. Friedman EL, Kruklitis RJ, Patson BJ, Sopka DM, Weiss MJ. Effectiveness of a thoracic multidisciplinary clinic in the treatment of stage III non-small-cell lung cancer. J Multidiscip Healthc. 2016;9:267.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Pan C-C, Kung P-T, Wang Y-H, Chang Y-C, Wang S-T, Tsai W-C. Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study. PLoS One. 2015;10(5):e0126547.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Stevens W, Stevens G, Kolbe J, Cox B. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations. Intern Med J. 2008;38(10):758–68.

    Article  CAS  PubMed  Google Scholar 

  13. Rogers MJ, Matheson L, Garrard B, Maher B, Cowdery S, Luo W, et al. Comparison of outcomes for cancer patients discussed and not discussed at a multidisciplinary meeting. Public Health. 2017;149:74–80.

    Article  CAS  PubMed  Google Scholar 

  14. Vinod SK, Sidhom MA, Delaney GP. Do multidisciplinary meetings follow guideline-based care? J Oncol Pract. 2010;6(6):276–81.

    Article  PubMed  PubMed Central  Google Scholar 

  15. American Society of Clinical Oncology, European Society for Medical Oncology. ASCO-ESMO consensus statement on quality cancer care. Ann Oncol. 2006;17(7):1063–4.

    Article  Google Scholar 

  16. Network NCCN. Non-small cell lung cancer (version 2.2023). J Natl Compr Canc Netw. 2023;21(4):340–50.

    Google Scholar 

  17. NIfHaC E Lung cancer: diagnosis and management. NICE Clinical Guideline 2011. Nice.org,uk/guidance/ng122/evidence/full-guideline-april2011-6722113501.

  18. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Clinical practice guidelines for the prevention, diagnosis and management of lung cancer. The Cancer Council Australia and Australian Cancer Network, National Health and Medical Research Council Canberra. 2004. Cancer.org.au/health-professionals/clinical-practice-guidelines/lung-cancer.

  19. Leo F, Venissac N, Poudenx M, Otto J, Mouroux J. Multidisciplinary management of lung cancer: how to test its efficacy? J Thorac Oncol. 2007;2(1):69–72.

    Article  PubMed  Google Scholar 

  20. World Health Organization. Framework for action on interprofessional education & collaborative practice; 2010.

    Google Scholar 

  21. Moody A, Muers M, Forman D. Delays in managing lung cancer. BMJ Publishing London; 2004. p. 1–3.

    Google Scholar 

  22. American Cancer Society. Key statistics for lung cancer. 2019. https://www.cancer.org/cancer/lung-cancer.html.

  23. Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57(3):253–60.

    Article  PubMed  Google Scholar 

  24. Osarogiagbon RU. Making the evidentiary case for universal multidisciplinary thoracic oncologic care. Clin Lung Cancer. 2018;19(4):294–300.

    Article  PubMed  Google Scholar 

  25. Kedia SK, Ward KD, Digney SA, Jackson BM, Nellum AL, McHugh L, et al. ‘One-stop shop’: lung cancer patients’ and caregivers’ perceptions of multidisciplinary care in a community healthcare setting. Transl Lung Cancer Res. 2015;4(4):456.

    PubMed  PubMed Central  Google Scholar 

  26. Gaga M, Powell CA, Schraufnagel DE, Schönfeld N, Rabe K, Hill NS, et al. An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer. Am J Respir Crit Care Med. 2013;188(4):503–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Denton E, Conron M. Improving outcomes in lung cancer: the value of the multidisciplinary health care team. J Multidiscip Healthc. 2016;9:137.

    PubMed  PubMed Central  Google Scholar 

  28. Osarogiagbon RU, Phelps G, McFarlane J, Bankole O. Causes and consequences of deviation from multidisciplinary care in thoracic oncology. J Thorac Oncol. 2011;6(3):510–6.

    Article  PubMed  Google Scholar 

  29. Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS. Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg. 2011;35(9):1970–6.

    Article  PubMed  Google Scholar 

  30. Rosell L, Alexandersson N, Hagberg O, Nilbert M. Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care. BMC Health Serv Res. 2018;18(1):1–10.

    Article  Google Scholar 

  31. Gamarra F, Noël J-L, Brunelli A, Dingemans A-MC, Felip E, Gaga M, et al. Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology. Breathe. 2016;12(3):249–55.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Meguid C, Ryan CE, Edil BH, Schulick RD, Gajdos C, Boniface M, et al. Establishing a framework for building multidisciplinary programs. J Multidiscip Healthc. 2015;8:519.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Spinks T, Guzman A, Beadle BM, Lee S, Jones D, Walters R, et al. Development and feasibility of bundled payments for the multidisciplinary treatment of head and neck cancer: a pilot program. J Oncol Pract. 2018;14(2):e103–e12.

    Article  PubMed  Google Scholar 

  34. Voong KR, Liang OS, Dugan P, Torto D, Padula WV, Senter JP, et al. Thoracic oncology multidisciplinary clinic reduces unnecessary health care expenditure used in the workup of patients with non–small-cell lung cancer. Clin Lung Cancer. 2019;20(4):e430–e41.

    Article  PubMed  Google Scholar 

  35. Freeman RK, Ascioti AJ, Dake M, Mahidhara RS. The effects of a multidisciplinary care conference on the quality and cost of care for lung cancer patients. Ann Thorac Surg. 2015;100(5):1834–8.

    Article  PubMed  Google Scholar 

  36. Stone CJ, Johnson AP, Robinson D, Katyukha A, Egan R, Linton S, et al. Health resource and cost savings achieved in a multidisciplinary lung cancer clinic. Curr Oncol. 2021;28(3):1681–95.

    Article  PubMed  PubMed Central  Google Scholar 

  37. van der Linden N, Bongers M, Coupé V, Smit E, Groen H, Welling A, et al. Costs of non-small cell lung cancer in The Netherlands. Lung Cancer. 2016;91:79–88.

    Article  PubMed  Google Scholar 

  38. Munro A. Multidisciplinary team meetings in cancer care: an idea whose time has gone? Clin Oncol. 2015;27(12):728–31.

    Article  CAS  Google Scholar 

  39. Quality AfHR. Working for quality annual report; 2011. www.ahrq.gov/qual/qrdr10.htm.

  40. Osarogiagbon RU, Freeman RK, Krasna MJ. Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs. Transl Lung Cancer Res. 2015;4(4):448.

    PubMed  PubMed Central  Google Scholar 

  41. Rankin NM, Fradgley EA, Barnes DJ. Implementation of lung cancer multidisciplinary teams: a review of evidence-practice gaps. Transl Lung Cancer Res. 2020;9(4):1667.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Iyer NG, Chua ML. Multidisciplinary team meetings—challenges of implementation science. Nat Rev Clin Oncol. 2019;16(4):205–6.

    Article  PubMed  Google Scholar 

  43. Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardiothorac Surg. 2010;38(1):1–5.

    Article  PubMed  Google Scholar 

  44. Wang J, Kuo YF, Freeman J, Goodwin JS. Increasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancer. Med Oncol. 2008;25(2):125–32.

    Article  PubMed  Google Scholar 

  45. Liu H, Song Y. MDT is still important in the treatment of early stage lung cancer. J Thorac Dis. 2018;10(Suppl 33):S3984.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Mackillop WJ. Killing time: the consequences of delays in radiotherapy. Radiother Oncol. 2007;84(1):1–4.

    Article  PubMed  Google Scholar 

  47. Vidaver RM, Shershneva MB, Hetzel SJ, Holden TR, Campbell TC. Typical time to treatment of patients with lung cancer in a multisite, US-based study. J Oncol Pract. 2016;12(6):e643–e53.

    Article  PubMed  Google Scholar 

  48. Albano D, Bilfinger T, Feraca M, Kuperberg S, Nemesure B. A multidisciplinary lung cancer program: does it reduce delay between diagnosis and treatment? Lung. 2020;198(6):967–72.

    Article  PubMed  Google Scholar 

  49. Albano D, Santore LA, Bilfinger T, Feraca M, Novotny S, Nemesure B. Clinical implications of “atypia” on biopsy: possible precursor to lung cancer? Curr Oncol. 2021;28(4):2516–22.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Liam CK, Andarini S, Lee P, Ho JCM, Chau NQ, Tscheikuna J. Lung cancer staging now and in the future. Respirology. 2015;20(4):526–34.

    Article  PubMed  Google Scholar 

  51. Liam C-K, Liam Y-S, Poh M-E, Wong C-K. Accuracy of lung cancer staging in the multidisciplinary team setting. Transl Lung Cancer Res. 2020;9(4):1654.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Tamburini N, Maniscalco P, Mazzara S, Maietti E, Santini A, Calia N, et al. Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study. Eur J Cardiothorac Surg. 2018;53(6):1199–204.

    Article  PubMed  Google Scholar 

  53. LeMense GP, Waller EA, Campbell C, Bowen T. Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program. BMC Pulm Med. 2020;20(1):1–8.

    Article  Google Scholar 

  54. Donington JS, Gitlitz B, Lim E, Opitz I, Kim YT, Altorki N. Integration of new systemic adjuvant therapies for non-small cell lung cancer: role of the surgeon. Ann Thorac Surg. 2023;115:1544.

    Article  PubMed  Google Scholar 

  55. Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022;386:1973.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Felip E, Altorki N, Zhou C, Csőszi T, Vynnychenko I, Goloborodko O, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet. 2021;398(10308):1344–57.

    Article  CAS  PubMed  Google Scholar 

  57. Paz-Ares L, O’Brien M, Mauer M, Dafni U, Oselin K, Havel L, et al. VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: randomized, triple-blind, phase III EORTC-1416-LCG/ETOP 8-15–PEARLS/KEYNOTE-091 study. Ann Oncol. 2022;33(4):451–3.

    Article  Google Scholar 

  58. Heinke MY, Vinod SK. A review on the impact of lung cancer multidisciplinary care on patient outcomes. Transl Lung Cancer Res. 2020;9(4):1639.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Bjegovich-Weidman M, Haid M, Kumar S, Huibregtse C, McDonald J, Krishnan S. Establishing a community-based lung cancer multidisciplinary clinic as part of a large integrated health care system: aurora health care. J Oncol Pract. 2010;6(6):e27–30.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Bydder S, Nowak A, Marion K, Phillips M, Atun R. The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer. Intern Med J. 2009;39(12):838–41.

    Article  CAS  PubMed  Google Scholar 

  61. Mitchell PL, Thursfield VJ, Ball DL, Richardson GE, Irving LB, Torn-Broers Y, et al. Lung cancer in Victoria: are we making progress? Med J Aust. 2013;199(10):674–9.

    Article  PubMed  Google Scholar 

  62. Bilfinger TV, Albano D, Perwaiz M, Keresztes R, Nemesure B. Survival outcomes among lung cancer patients treated using a multidisciplinary team approach. Clin Lung Cancer. 2018;19(4):346–51.

    Article  PubMed  Google Scholar 

  63. Kehl KL, Landrum MB, Kahn KL, Gray SW, Chen AB, Keating NL. Tumor board participation among physicians caring for patients with lung or colorectal cancer. J Oncol Pract. 2015;11(3):e267–e78.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Davison A, Eraut C, Haque A, Doffman S, Tanqueray A, Trask C, et al. Telemedicine for multidisciplinary lung cancer meetings. J Telemed Telecare. 2004;10(3):140–3.

    Article  CAS  PubMed  Google Scholar 

  65. Boxer MM, Vinod SK, Shafiq J, Duggan KJ. Do multidisciplinary team meetings make a difference in the management of lung cancer? Cancer. 2011;117(22):5112–20.

    Article  PubMed  Google Scholar 

  66. Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ. Tumor boards and the quality of cancer care. J Natl Cancer Inst. 2013;105(2):113–21.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Batra U, Munshi A, Kabra V, Momi G. Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC. Indian J Cancer. 2022;59(Suppl 1):S46.

    Article  PubMed  Google Scholar 

  68. Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, et al. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol. 2006;24(4):635–42.

    Article  PubMed  Google Scholar 

  69. Murray P, O’Brien M, Sayer R, Cooke N, Knowles G, Miller A, et al. The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway. Lung Cancer. 2003;42(3):283–90.

    Article  CAS  PubMed  Google Scholar 

  70. Senter J, Hooker C, Lang M, Voong K, Hales R. Thoracic multidisciplinary clinic improves survival in patients with lung cancer. Int J Radiat Oncol Biol Phys. 2016;96(2):S134.

    Article  Google Scholar 

  71. Price A, Kerr G, Gregor A, Ironside J, Little F. The impact of multidisciplinary teams and site specialisation on the use of radiotherapy in elderly people with non-small cell lung cancer (NSCLC). Radiother Oncol. 2002;64(Suppl 1):80.

    Google Scholar 

  72. Forrest L, McMillan D, McArdle C, Dunlop D. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2005;93(9):977–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Stone E, Rankin N, Kerr S, Fong K, Currow DC, Phillips J, et al. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study. Lung Cancer. 2018;124:199–204.

    Article  PubMed  Google Scholar 

  74. Riedel RF, Wang X, McCormack M, Toloza E, Montana GS, Schreiber G, et al. Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care. J Thorac Oncol. 2006;1(7):692–6.

    PubMed  Google Scholar 

  75. Bertolaccini L, Mohamed S, Bardoni C, Lo Iacono G, Mazzella A, Guarize J, et al. The Interdisciplinary Management of Lung Cancer in the European community. J Clin Med. 2022;11(15):4326.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Lin T, Pham J, Paul E, Conron M, Wright G, Ball D, et al. Impacts of lung cancer multidisciplinary meeting presentation: drivers and outcomes from a population registry retrospective cohort study. Lung Cancer. 2022;163:69–76.

    Article  PubMed  Google Scholar 

  77. Hung H-Y, Tseng Y-H, Chao H-S, Chiu C-H, Hsu W-H, Hsu H-S, et al. Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer. PLoS One. 2020;15(10):e0236503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Gaudioso C, Sykes A, Whalen PE, Attwood KM, Masika MM, Demmy TL, et al. Impact of a thoracic multidisciplinary conference on lung cancer outcomes. Ann Thorac Surg. 2022;113(2):392–8.

    Article  PubMed  Google Scholar 

  79. Round T, L’Esperance V, Bayly J, Brain K, Dallas L, Edwards JG, et al. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary. Br J Cancer. 2021;125(5):629–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Popat S, Navani N, Kerr KM, Smit EF, Batchelor TJP, Van Schil P, et al. Navigating diagnostic and treatment decisions in non-small cell lung cancer: expert commentary on the multidisciplinary team approach. Oncologist. 2020;26(2):e306–e15.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Sanchez JI, Doose M, Zeruto C, Chollette V, Gasca N, Verhoeven D, et al. Multilevel factors associated with inequities in multidisciplinary cancer consultation. Health Serv Res. 2022;57:222.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA

    Thomas Bilfinger, Lee Ann Santore & Barbara Nemesure

  2. Stony Brook Chest Clinic, Stony Brook University Hospital, Stony Brook, NY, USA

    Thomas Bilfinger & Barbara Nemesure

  3. Department of Surgery, Stony Brook University, Stony Brook, NY, USA

    Thomas Bilfinger

  4. Department of Family, Population and Preventive, Medicine, Stony Brook University, Stony Brook, NY, USA

    Barbara Nemesure

Authors
  1. Thomas Bilfinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lee Ann Santore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara Nemesure
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Bilfinger .

Editor information

Editors and Affiliations

  1. Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina, Chapel Hill, NC, USA

    Christina R. MacRosty

  2. Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center, Rochester, NY, USA

    M. Patricia Rivera

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bilfinger, T., Santore, L.A., Nemesure, B. (2023). Multidisciplinary Approach to Lung Cancer Care. In: MacRosty, C.R., Rivera, M.P. (eds) Lung Cancer. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-031-38412-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-38412-7_12

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-031-38411-0

  • Online ISBN: 978-3-031-38412-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation